市場調査レポート

商品コード

1624009

多汗症治療の市場規模、シェア、成長分析、タイプ別、治療法別、年齢別、エンドユーザー別、地域別-産業予測、2025～2032年

Hyperhidrosis Treatment Market Size, Share, Growth Analysis, By Type (Axillary hyperhidrosis, Palmar hyperhidrosis), By Treatment (Topical treatment, Oral medication), By Age, By End-user, By Region - Industry Forecast 2025-2032

出版日: 2025年01月02日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 778,888円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,152円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,416円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.96円

全表示
概要
目次

概要

サンプル依頼リストに入れる

多汗症治療の世界市場規模は2023年に6億7,120万米ドルと評価され、予測期間（2025～2032年）のCAGRは5.4％で成長し、2024年の7億744万米ドルから2032年には10億7,750万米ドルに拡大する見通しです。

多汗症治療市場は、研究開発投資の活発化と二次性多汗症疾患の有病率の上昇によって大きな成長を遂げています。恒久的な治療法が存在しないため、制汗剤や外用液が依然として第一の治療法となっています。革新的な治療オプションに対する患者の嗜好の高まりが、各社の製品強化に拍車をかけています。2021年10月にJared Brackenrichによって発表された研究によると、現在、多汗症は米国人口の約3％が罹患しており、この症状が社会的、心理的、職業的機能に影響を及ぼすことが強調されています。さらに、開発中の有望な治療法、有利な償還政策、社会的認知度の向上が需要を促進する可能性が高いです。特に、Brickell Biotech社の臭化ソフピロニウムゲルの第3相臨床試験は、先進的多汗症治療の強い将来性を示しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

AbbVie Inc.（US）
Avanor Healthcare Ltd.（UK）
Brickell Biotech Inc.（US）
Dermadry Laboratories Inc.（Canada）
Dermavant Sciences Inc.（US）
Hugel, Inc.（South Korea）
Eirion Therapeutics, Inc.（US）
Eli Lilly and Company（US）
Intas Pharmaceuticals Ltd.（India）
Kaken Pharmaceutical Co., Ltd.（Japan）
Maruho Co., Ltd.（Japan）
miraDry, Inc.（US）
SweatBlock（US）
Roivant Sciences Ltd.（Switzerland）
Theravida, Inc.（US）
Dr. August Wolff GmbH（Germany）
Dr. Reddy's Laboratories Ltd.（India）
GSK Plc（UK）
Revance（US）
NovaMedica（Russia）

結論と推奨事項

Product Code: SQSG35J2014

Global Hyperhidrosis Treatment Market size was valued at USD 671.2 million in 2023 and is poised to grow from USD 707.44 million in 2024 to USD 1077.5 million by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).

The hyperhidrosis treatment market is witnessing significant growth driven by heightened R&D investment and a rising prevalence of secondary hyperhidrosis disorders. Antiperspirants and topical solutions remain the frontline therapies as no permanent cure exists. The growing patient preference for innovative treatment options has spurred companies to enhance their offerings. Currently, hyperhidrosis affects about 3% of the U.S. population, according to a study published by Jared Brackenrich in October 2021, underscoring the condition's impact on social, psychological, and vocational functioning. Additionally, promising therapies in the pipeline, favorable reimbursement policies, and increasing public awareness are likely to fuel demand. Notably, Brickell Biotech's Phase 3 trials of sofpironium bromide gel indicate a strong future potential for advanced hyperhidrosis treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hyperhidrosis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hyperhidrosis Treatment Market Segmental Analysis

Global Hyperhidrosis Treatment Market is segmented by Type, Treatment, Age, End-user and region. Based on Type, the market is segmented into Axillary hyperhidrosis, Palmar hyperhidrosis, Plantar hyperhidrosis and Other types. Based on Treatment, the market is segmented into Topical treatment, Oral medication, Botulinum toxin injections, Iontophoresis and Surgical treatment. Based on Age, the market is segmented into Up to 50 years and Above 50 years. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers, Dermatology clinics and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hyperhidrosis Treatment Market

The Global Hyperhidrosis Treatment market is driven by a growing interest among healthcare providers in exploring advanced therapies such as radiofrequency microneedling for hyperhidrosis patients. Researchers are particularly focused on assessing the long-term effectiveness of fractional microneedle radiofrequency treatments for individuals with primary axillary hyperhidrosis, utilizing the hyperhidrosis disease severity scale (HDSS) to measure significant improvements post-treatment. Additionally, tap water iontophoresis is gaining traction, demonstrating notable results in clinical trials for patients suffering from plantar and palmar hyperhidrosis. Innovations in treatment options are being propelled by recent successful studies, including the positive Phase 3 results from Brickell Biotech Inc. regarding sofpironium bromide gel, highlighting the market's potential for growth and enhanced patient quality of life.

Restraints in the Global Hyperhidrosis Treatment Market

The Global Hyperhidrosis Treatment market faces notable challenges, one of which is the limited duration of effectiveness associated with Botulinum toxin injections; patients often develop a reduced response to these treatments over time. Additionally, the financial implications and emotional strain on patients pose significant obstacles, as many insurance providers do not reimburse expenses related to hyperhidrosis treatments. This lack of coverage not only adds to the economic burden for individuals seeking relief but also contributes to their psychological distress, potentially leading to decreased treatment adherence and limiting market growth opportunities in this sector.

Market Trends of the Global Hyperhidrosis Treatment Market

The Global Hyperhidrosis Treatment market is witnessing significant growth, driven by an increasing awareness of excessive sweating conditions and the effectiveness of advanced treatment options like onabotulinumtoxinA (Botox). With its clinically proven ability to reduce sweating by 82-87% and long-lasting effects that can endure up to 14 months, Botox has become a preferred treatment choice among patients. The market is further propelled by innovations in minimally invasive procedures, a growing prevalence of hyperhidrosis, and a rise in disposable income allowing for aesthetic treatments. As demand expands, the market is poised for continued advancement through research and new therapeutic options.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies

Global Hyperhidrosis Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Axillary hyperhidrosis
Palmar hyperhidrosis
Plantar hyperhidrosis
Other types

Global Hyperhidrosis Treatment Market Size by Treatment & CAGR (2025-2032)

Market Overview
Topical treatment
Oral medication
- Anticholinergics
- Other oral medications
Botulinum toxin injections
Iontophoresis
Surgical treatment

Global Hyperhidrosis Treatment Market Size by Age & CAGR (2025-2032)

Market Overview
Up to 50 years
Above 50 years

Global Hyperhidrosis Treatment Market Size by End-user & CAGR (2025-2032)

Market Overview
Hospitals
Ambulatory Surgical Centers
Dermatology clinics
Other end-users

Global Hyperhidrosis Treatment Market Size & CAGR (2025-2032)

North America (Type, Treatment, Age, End-user)
- US
- Canada
Europe (Type, Treatment, Age, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Treatment, Age, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Treatment, Age, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Treatment, Age, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avanor Healthcare Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Brickell Biotech Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dermadry Laboratories Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dermavant Sciences Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hugel, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eirion Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intas Pharmaceuticals Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaken Pharmaceutical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maruho Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
miraDry, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SweatBlock (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roivant Sciences Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Theravida, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. August Wolff GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revance (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NovaMedica (Russia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

多汗症治療の市場規模、シェア、成長分析、タイプ別、治療法別、年齢別、エンドユーザー別、地域別-産業予測、2025～2032年

Hyperhidrosis Treatment Market Size, Share, Growth Analysis, By Type (Axillary hyperhidrosis, Palmar hyperhidrosis), By Treatment (Topical treatment, Oral medication), By Age, By End-user, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

多汗症治療の市場規模：タイプ別& CAGR（2025-2032）

多汗症治療の市場規模：治療法別& CAGR（2025-2032）

多汗症治療の市場規模：年齢別& CAGR（2025-2032）

多汗症治療の市場規模：エンドユーザー別& CAGR（2025-2032）

多汗症治療市場規模：地域別& CAGR（2025-2032）